Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Karel M Van Praet , Christof Stamm , Simon H Sündermann , et al Added: 3 years ago
Reconstructive valve surgery encompasses a comprehensive system of valve analysis and related techniques based on three basic principles as described by Alain Carpentier and colleagues: restoring or preserving the full mobility of the leaflets, creating a large surface of leaflet coaptation and remodelling the annulus to provide an optimal and stable orifice area.1 Mitral valve regurgitation (MR)… View more
Author(s): Ricardo Boix-Garibo , Mohammed Mohsin Uzzaman , Vinayak Bapat Added: 3 years ago
Aortic valve replacement via full sternotomy is the gold standard surgical therapy for patients with severe aortic stenosis (AS) and insufficiency.1 This procedure has proved to be reliable, reproducible, relieves symptoms and improves prognosis of the patients. Degenerative AS is the most frequently acquired valve disease in the elderly population. In the current era, aortic valve surgery is the… View more
Author(s): Lutz Buellesfeld , Ulrich Gerckens Added: 3 years ago
Surgical aortic valve replacement is the reference standard for patients with symptomatic severe aortic valve stenosis.1,2 Despite the fact that the prognosis with medical management is poor, many patients do not undergo surgery due to an increased anticipated operative risk, driven by co-morbidities such as pulmonary hypertension, severe obstructive pulmonary disease, previous cardiac surgery,… View more
Author(s): Grégory Ducrocq , Dominique Himbert , Eric Brochet , et al Added: 3 years ago
Aortic stenosis (AS) is currently the most frequent native valve disease in Europe and is most often seen in elderly patients with co-morbidities.1 Valve replacement is the definitive therapy for patients with severe AS who have symptoms or objective consequences such as left ventricular (LV) dysfunction.2,3 However, the risk of surgery may be higher in elderly patients with significant co… View more
Author(s): Thomas Walther , Johannes Blumenstein Added: 3 years ago
During the past five years, transcatheter (T) aortic valve implantation (AVI) has evolved as one of the most important clinical innovations in cardiovascular disease. The specific merit of TAVI is to allow for minimally invasive treatment of severe symptomatic aortic stenosis (AS) in elderly and high-risk patients. Since 2005 retrograde transfemoral (TF) and antegrade transapical (TA) aortic… View more
Author(s): John Jose , Gert Richardt , Mohamed Abdel-Wahab Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) has undergone tremendous technological advancements since the first successful implantation in 2002 for symptomatic severe aortic valve stenosis (AS).1 It is currently considered as the standard of care for severe AS patients who have high surgical risk or may be deemed unsuitable for surgery.2 Broadly, there are two main categories of transcatheter… View more
Author(s): Michael Lauterbach , Bruno Sontag , Karl-Eugen Hauptmann Added: 3 years ago
Over the past nine years, since the first transcatheter aortic valve implantation (TAVI) by Cribier et al.1 in France in 2002, this new technique has enthralled cardiologists all over the world. With the deployment of TAVI – about 40,000 procedures have been carried out worldwide so far – cardiologists intruded into the previously unshared domain of surgical aortic valve replacement. Albeit… View more